In vitro evaluation of biofilm formation by Candida parapsilosis and Enterobacter cloacae. Scanning electron microscopy and efficacy of antimicrobial combinations study

Diagn Microbiol Infect Dis. 2023 Sep;107(1):116003. doi: 10.1016/j.diagmicrobio.2023.116003. Epub 2023 Jun 8.

Abstract

Fungal-bacterial infections are being increasingly recognized in clinical settings, and the interaction between these species in polymicrobial biofilms often lead to infections that are highly resistant to treatment. In this in vitro study, we analyzed the formation of mixed biofilms using clinically isolated Candida parapsilosis and Enterobacter cloacae. Additionally, we assessed the potential of conventional antimicrobials, both alone and in combination, for treating polymicrobial biofilms built by these human pathogens. Our results demonstrate that C. parapsilosis and E. cloacae are capable of forming mixed biofilms, as confirmed by scanning electron microscopy. Interestingly, we found that colistin alone or in combination with antifungal drugs was highly effective reducing up to 80% of the total biomass of polymicrobial biofilms.

Keywords: Antimicrobials; Candida parapsilosis; Enterobacter cloacae; Infections; Mixed biofilm.

MeSH terms

  • Anti-Infective Agents* / pharmacology
  • Antifungal Agents / pharmacology
  • Biofilms
  • Candida
  • Candida parapsilosis*
  • Enterobacter cloacae
  • Humans
  • Microbial Sensitivity Tests
  • Microscopy, Electron, Scanning

Substances

  • Anti-Infective Agents
  • Antifungal Agents